Close Menu

NEW YORK — OpGen said on Thursday that it has priced its planned $9.4 million stock and warrant offering.

The Gaithersburg, Maryland-based company said it will sell 4.7 million units, comprising one share of common stock and one warrant to buy one share of common stock, for $2 apiece. OpGen said it expects to gross $9.4 million through the transaction, although it has also granted the underwriters of the offering an option to purchase an additional 705,000 common shares and/or warrants to purchase up to 705,000 shares.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jan
28
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Feb
05
Sponsored by
LGC

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.